GIP (3-42), human acetate is an antagonist of a glucose-dependent insulinotropic polypeptide (GIP) receptor and regulates insulin secretion and GIP metabolism in vivo.
Target:
IGF-1R
T37589L
* VAT and and shipping costs not included. Errors and price changes excepted